z-logo
open-access-imgOpen Access
Dual inhibition of RNAi therapeutic miR-26a-5p targeting cMet and immunotherapy against EGFR in endometrial cancer treatment
Author(s) -
Yun Liu,
Yixuan Cai,
Yue Chang
Publication year - 2021
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-20-3166
Subject(s) - cancer research , epidermal growth factor receptor , cell growth , in vivo , cell culture , cetuximab , chemistry , hepatocyte growth factor , biology , monoclonal antibody , receptor , antibody , immunology , biochemistry , genetics , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom